Browse by Title

78 items found

Showing titles from 50 to 75:

  1  2  3  4   
FormatDateTitleAuthor
FormatDateTitleAuthor
doc icon DUGiDocs 2011 Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat 2018 June 5 Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
doc icon TDX 2013 June 21 Nous mecanismes de resistència primària al trastuzumab (Herceptin): bases moleculars per a la determinació d’un nou subtipus de càncer de mama (Basal/ErbB2+) Oliveras Ferrarós, Cristina
out url icon Recercat Nous mecanismes de resistència primària al trastuzumab (Herceptin): bases moleculars per a la determinació d’un nou subtipus de càncer de mama (Basal/ErbB2+) Oliveras Ferrarós, Cristina
doc icon DUGiDocs 2015 Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuyàs, Elisabet ; Fernández Arroyo, Salvador ; Corominas Faja, Bruna ; Rodríguez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Llorens Duran, Rafael de ; Joven, Jorge ; Menéndez Menéndez, Javier Abel
out url icon Recercat Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuyàs, Elisabet ; Fernández Arroyo, Salvador ; Corominas Faja, Bruna ; Rodríguez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Llorens Duran, Rafael de ; Joven, Jorge ; Menéndez Menéndez, Javier Abel
out url icon Recercat Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuyàs, Elisabet ; Fernández Arroyo, Salvador ; Corominas Faja, Bruna ; Rodríguez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Llorens Duran, Rafael de ; Joven, Jorge ; Menéndez Menéndez, Javier Abel
out url icon Recercat 2018 June 5 Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype Cuyàs, Elisabet ; Fernández Arroyo, Salvador ; Corominas Faja, Bruna ; Rodríguez Gallego, Esther ; Bosch Barrera, Joaquim ; Martin Castillo, Begoña ; Llorens Duran, Rafael de ; Joven, Jorge ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 2017 June Paper jugat pel receptor ErbB-3 (HER-3) en el desenvolupament i tractament del càncer Cortés i Andrés, Adrià
out url icon Recercat Paper jugat pel receptor ErbB-3 (HER-3) en el desenvolupament i tractament del càncer Cortés i Andrés, Adrià
doc icon TDX 1994 December 16 PurificaciĂł, caracteritzaciĂł i clonatge de la ribonucleasa de pĂ ncreas humĂ  RibĂł i Panosa, Marc
out url icon Recercat PurificaciĂł, caracteritzaciĂł i clonatge de la ribonucleasa de pĂ ncreas humĂ  RibĂł i Panosa, Marc
doc icon DUGiDocs 2008 Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Colomer, Ramon ; Llorens Duran, Rafael de ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Colomer, Ramon ; Llorens Duran, Rafael de ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Colomer, Ramon ; Llorens Duran, Rafael de ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat 2018 June 5 Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Colomer, Ramon ; Llorens Duran, Rafael de ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 2016 September 12 Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer Queralt, Bernardo ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Massaguer i Vall-llovera, Anna ; Llorens Duran, Rafael de ; Martin Castillo, Begoña ; Brunet i Vidal, Joan ; Salazar, Ramon ; Menéndez Menéndez, Javier Abel
out url icon Recercat Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer Queralt, Bernardo ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Massaguer i Vall-llovera, Anna ; Llorens Duran, Rafael de ; Martin Castillo, Begoña ; Brunet i Vidal, Joan ; Salazar, Ramon ; Menéndez Menéndez, Javier Abel
out url icon Recercat Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer Queralt, Bernardo ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Massaguer i Vall-llovera, Anna ; Llorens Duran, Rafael de ; Martin Castillo, Begoña ; Brunet i Vidal, Joan ; Salazar, Ramon ; Menéndez Menéndez, Javier Abel
out url icon Recercat 2018 June 5 Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer Queralt, Bernardo ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Massaguer i Vall-llovera, Anna ; Llorens Duran, Rafael de ; Martin Castillo, Begoña ; Brunet i Vidal, Joan ; Salazar, Ramon ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 2012 Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment Oliveras Ferrarós, Cristina ; Massaguer i Vall-llovera, Anna ; Vázquez Martín, Alejandro ; Carrion Salip, Dolors ; Queralt, Bernardo ; Cufí González, Sílvia ; Martin Castillo, Begoña ; Bosch Barrera, Joaquim ; Brunet i Vidal, Joan ; Llorens Duran, Rafael de ; Menéndez Menéndez, Javier Abel
out url icon Recercat Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment Oliveras Ferrarós, Cristina ; Massaguer i Vall-llovera, Anna ; Vázquez Martín, Alejandro ; Carrion Salip, Dolors ; Queralt, Bernardo ; Cufí González, Sílvia ; Martin Castillo, Begoña ; Bosch Barrera, Joaquim ; Brunet i Vidal, Joan ; Llorens Duran, Rafael de ; Menéndez Menéndez, Javier Abel
out url icon Recercat Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment Oliveras Ferrarós, Cristina ; Massaguer i Vall-llovera, Anna ; Vázquez Martín, Alejandro ; Carrion Salip, Dolors ; Queralt, Bernardo ; Cufí González, Sílvia ; Martin Castillo, Begoña ; Bosch Barrera, Joaquim ; Brunet i Vidal, Joan ; Llorens Duran, Rafael de ; Menéndez Menéndez, Javier Abel
  1  2  3  4   

Subjects

Authors